Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration

Stravalaci, Matteo; Davi, Francesca; Parente, Raffaella; Gobbi, Marco; Bottazzi, Barbara; Mantovani, Alberto; Day, Anthony J.; Clark, Simon J.; Romano, Mario R.; Inforzato, Antonio

dc.contributor.author	Clark, Simon
dc.date.accessioned	2021-04-19T08:02:49Z
dc.date.available	2021-04-19T08:02:49Z
dc.date.issued	2020
dc.identifier.issn	1663-9812
dc.identifier.uri	http://hdl.handle.net/10900/114321
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fphar.2020.591908	de_DE
dc.subject.ddc	610	de_DE
dc.title	Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_00504
utue.personen.roh	Stravalaci, Matteo
utue.personen.roh	Davi, Francesca
utue.personen.roh	Parente, Raffaella
utue.personen.roh	Gobbi, Marco
utue.personen.roh	Bottazzi, Barbara
utue.personen.roh	Mantovani, Alberto
utue.personen.roh	Day, Anthony J.
utue.personen.roh	Clark, Simon J.
utue.personen.roh	Romano, Mario R.
utue.personen.roh	Inforzato, Antonio
dcterms.isPartOf.ZSTitelID	Frontiers in Pharmacology	de_DE
dcterms.isPartOf.ZS-Issue	Article 591908	de_DE
dcterms.isPartOf.ZS-Volume	11	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE